gastro-jРоссийский журнал гастроэнтерологии, гепатологии, колопроктологииRussian Journal of Gastroenterology, Hepatology, Coloproctology1382-43762658-6673«Gastro» LLC10.22416/1382-4376-2024-34-2-101-131gastro-j-1222Research ArticleКЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИCLINICAL GUIDELINESДиагностика и лечение язвенной болезни у взрослых (Клинические рекомендации Российской гастроэнтерологической ассоциации, Российского общества колоректальных хирургов, Российского эндоскопического общества и Научного сообщества по содействию клиническому изучению микробиома человека)Diagnostics and Treatment of Peptic Ulcer in Adults (Clinical Guidelines of the Russian Gastroenterological Association, the Russian Society of Colorectal Surgeons, the Russian Endoscopic Society and the Scientific Society for the Clinical Study of Human Microbiome)https://orcid.org/0000-0002-6815-6015ИвашкинВ. Т.IvashkinV. Т.

Ивашкин Владимир Трофимович — доктор медицинских наук, профессор, академик РАН, заведующий кафедрой пропедевтики внутренних болезней, гастроэнтерологиии  гепатологии

119435, г. Москва, ул. Погодинская, 1, стр. 1

Vladimir T. Ivashkin — Dr. Sci. (Med.), Professor, Academician of the Russian Academy of Sciences, Head of the Department of Propaedeutics of Internal Disease, Gastroenterologyand  Hepatology

119435, Moscow, Pogodinskaya str., 1, build. 1

ivashkin_v_t@staff.sechenov.ruhttps://orcid.org/0000-0001-6114-564XМаевИ. В.MayevI. V.

Маев Игорь Вениаминович — доктор медицинских наук, профессор, академик РАН, заведующий кафедрой пропедевтики внутренних болезней и гастроэнтерологии

127473, г. Москва, ул. Делегатская, 20, стр. 1

Igor V. Maev — Dr. Sci. (Med.), Professor, Academician of the Russian Academy of Medical Sciences, Head of the Department of Propaedeutics of Internal Diseases and Gastroenterology

127473, Moscow, Delegatskaya str., 20, build. 1

igormaev@rambler.ruhttps://orcid.org/0000-0002-7134-6821ЦарьковП. В.TsarkovР. V.

Царьков Петр Владимирович — доктор медицинских наук, профессор, заведующий кафедрой хирургии

119435, г. Москва, ул. Погодинская, 1, стр. 1

Petr V. Tsarkov — Dr. Sci. (Med.), Professor, Head of  the Department of Surgery

119435, Moscow, Pogodinskaya str., 1, build. 1

tsarkov@kkmx.ruhttps://orcid.org/0000-0001-5061-0139КоролевМ. П.KorolevМ. Р.

Королев Михаил Павлович — доктор медицинских наук, заведующий кафедрой общей хирургии с курсом эндоскопии

119014, г. Санкт-Петербург, Литейный проспект, 56

Mikhail P. Korolev — Dr. Sci. (Med.), Head of the Departament of General Surgery with an Endoscopy Course

119014, St. Petersburg, Liteiny ave., 56

korolevmp@yandex.ruhttps://orcid.org/0000-0002-4007-7112АндреевД. Н.AndreevD. N.

Андреев Дмитрий Николаевич — кандидат медицинских наук, доцент кафедры пропедевтики внутренних болезней и гастроэнтерологии

127473, г. Москва, ул. Делегатская, 20, стр. 1

Dmitry N. Andreev – Cand. Sci. (Med.), Associate Professor at the Department of Propaedeutics of Internal Diseases and Gastro-enterology

127473, Moscow, Delegatskaya str., 20, build. 1

dna-mit8@mail.ruhttps://orcid.org/0000-0002-9971-8295БаранскаяЕ. К.BaranskayaЕ. К.

Баранская Елена Константиновна — доктор медицинских наук, профессор кафедры пропедевтики внутренних болезней лечебного факультета

119435, г. Москва, ул. Погодинская, 1, стр. 1

Elena K. Baranskaya — Dr. Sci. (Med.), Professor of the Department of Propaedeutics of Internal Diseases

119435, Moscow, Pogodinskaya str., 1, build. 1

ebaranskaya@yandex.ruБординД. С.BordinD. S.

Бордин Дмитрий Станиславович — доктор медицинских наук, профессор кафедры пропедевтики внутренних болезней и гастроэнтерологии; заведующий отделом патологии поджелудочной железы, желчных путей и верхних отделов пищеварительного тракта; профессор кафедры общей врачебной практики и семейной медицины ФПДО

111123, г. Москва, шоссе Энтузиастов, 86, стр. 6

Dmitry S. Bordin — Dr. Sci. (Med.), Professor of the Department of Internal Medicine Propaedeutics and Gastroenterology; Head of the Department of Pancreatic, Bile andUpper Gastrointestinal Pathology; Professor of the Department of GeneralMedical Practice and Family Medicine

111123, Moscow, Entuziastov highway, 86, build. 6

БурковС. Г.BurkovS. G.

Бурков Сергей Геннадьевич — доктор медицинских наук, профессор, заместитель главного врача

119090, г. Москва, Грохольский пер., 31

Sergey G. Bourkov — Dr. Sci. (Med.), Professor, Deputy Chief Physician

119090, Moscow, Grokholsky lane, 31

bourk@mail.ruhttps://orcid.org/0000-0001-9449-5945ДериновА. А.DerinovА. А.

Деринов Александр Александрович — кандидат медицинских наук, доцент кафедры хирургии Института клинической медицины

119435, г. Москва, ул. Погодинская, 1, стр. 1

Alexander A. Derinov — Cand. Sci. (Med.), Associate Professor at the Department of Surgery, Institute of Clinical Medicine

119435, Moscow, Pogodinskaya str., 1, build. 1

alexandr.derinov@gmail.comhttps://orcid.org/0000-0003-0283-2217ЕфетовС. К.EfetovS. К.

Ефетов Сергей Константинович — кандидат медицинских наук, доцент кафедры хирургии Института клинической медицины им. Н.В. Склифосовского, заведующий хирургическим отделением № 2 Университетской клинической больницы № 4

119435, г. Москва, ул. Большая Пироговская, 2–4

Sergey K. Efetov — Cand. Sci. (Med.), Associate Professor at the Department of Surgery, Institute of Clinical Medicine named after. N.V. Sklifosovsky, Head of Surgical DepartmentNo. 2, University Clinical Hospital No. 4

119435, Moscow, Bolshaya Pirogovskaya str., 2–4

efetov@mail.ruhttps://orcid.org/0000-0003-4456-8725ЛапинаТ. Л.LapinaТ. L.

Лапина Татьяна Львовна — кандидат медицинских наук, доцент кафедры пропедевтики внутренних болезней гастроэнтерологии, гепатологии

119435, г. Москва, ул. Погодинская, 1, стр. 1

 

Tatiana L. Lapina — Cand. Sci. (Med.), Associate Professor at the Department of Propaedeutics of Internal Diseases

119435, Moscow, Pogodinskaya str., 1, build. 1

lapina_t_l@staff.sechenov.ruhttps://orcid.org/0000-0002-4391-5441ПавловП. В.PavlovР. V.

Павлов Павел Владимирович — кандидат медицинских наук, заведующий отделением диагностической и лечебной эндоскопии Университетской клинической больницы № 2

119435, г. Москва, ул. Погодинская, 1, стр. 1

Pavel V. Pavlov — Cand. Sci. (Med.), Head of the Department of Diagnostic and Therapeutic Endoscopy, University Clinical Hospital No. 2

119435, Moscow, Pogodinskaya str., 1, build. 1

pvpavlov@yandex.ruhttps://orcid.org/0000-0002-8101-2155ПироговС. С.PirogovS. S.

Пирогов Сергей Сергеевич — доктор медицинских наук, заведующий отделом эндоскопии

125284, г. Москва, 2-й Боткинский пр., 3

Sergey S. Pirogov — Dr. Sci. (Med.), Dr. Sci. (Med.), Head of the Department of Endoscopy

125284, Moscow, 2st Botkinsky lane, 3

pirogov@mail.ruhttps://orcid.org/0000-0003-1312-120XПолуэктоваЕ. А.PoluektovaЕ. А.

Полуэктова Елена Александровна — доктор медицинских наук, профессор кафедры пропедевтики внутренних болезней, гастроэнтерологии и гепатологии

119435, г. Москва, ул. Погодинская, 1, стр. 1

Elena A. Poluektova — Dr. Sci. (Med.), Professor at the Department of  InternalDiseasePropaedeutics, Gastroenterology and Hepatology

119991, Moscow, Pogodinskaya str., 1, build. 1

poluektova_e_a@staff.sechenov.ruhttps://orcid.org/0000-0002-5554-7084ТкачевА. В.TkachevА. V.

Ткачев Александр Васильевич — доктор медицинских наук, профессор, заведующий кафедрой пропедевтики внутренних болезней

344022, г. Ростов-на-Дону, Нахичеванский пер., 29

Alexander V. Tkachev — Dr. Sci. (Med.), Professor, Head of  the Department of Propaedeutics of Internal Diseases

344022, Rostov-on-Don, Nakhichevansky lane, 29

tkachev@aaanet.ruhttps://orcid.org/0000-0003-3362-2968ТрухмановА. С.TrukhmanovА. S.

Трухманов Александр Сергеевич — доктор медицинских наук, профессор кафедры пропедевтики внутренних болезней, гастроэнтерологии и гепатологии Института клинической медицины им. Н.В. Склифосовского

119435, г. Москва, ул. Погодинская, 1, стр. 1

Alexander S. Trukhmanov — Dr. Sci. (Med.), Professor at  the Department of Propaedeutics of Internal Diseases, Gastroenterology and Hepatology

119991, Moscow, Pogodinskaya str., 1, build. 1

alexander.trukhmanov@gmail.comhttps://orcid.org/0000-0001-5506-5555УльянинА. И.UljaninА. I.

Ульянин Анатолий Игоревич — врач-гастроэнтеролог отделения хронических заболеваний кишечника и поджелудочной железы клиники пропедевтики внутренних болезней, гастроэнтерологии и гепатологии им. В.Х. Василенко

119435, г. Москва, ул. Погодинская, 1, стр. 1

Anatoly I. Ulyanin — Gastroenterologist, Department of Chronic Intestinal and Pancreatic Diseases, V.Kh. Vasilenko Clinic of Propaedeutics of Internal Disease, Gastroenterologyand Hepatology

119435, Moscow, Pogodinskaya str., 1, build. 1

ulyanin_a_i@staff.sechenov.ruhttps://orcid.org/0000-0002-6036-7061ФедоровЕ. Д.FedorovЕ. D.

Федоров Евгений Дмитриевич — доктор медицинских наук, профессор, главный научный сотрудник научно-исследовательской лаборатории хирургической гастроэнтерологии и  эндоскопии; клинический руководитель отделения эндоскопической хирургии

117997, г. Москва, ул. Островитянова, 1

 

Evgeny D. Fedorov — Dr. Sci. (Med.), Professor, Chief Researcher, Research Laboratory of Surgical Gastroenterology and Endoscopy; Clinical Head of the Departmentof Endoscopic Surgery

117997, Moscow, Ostrovityanova str., 1

https://orcid.org/0000-0002-1395-9566ШептулинА. А.SheptulinА. А.

Шептулин Аркадий Александрович — доктор медицинских наук, профессор кафедры пропедевтики внутренних болезней, гастроэнтерологии и гепатологии

119435, г. Москва, ул. Погодинская, 1, стр. 1

Arkady A. Sheptulin — Dr. Sci. (Med.), Professor at the Department of Propaedeutics of Internal Diseases, Gastroenterology and  Hepatology

119435, Moscow, Pogodinskaya str., 1, build. 1

arkalshep@gmail.comФГАОУ ВО «Первый Московский государственный университет им. И.М. Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский университет)РоссияI.M. Sechenov First Moscow State Medical University (Sechenov University)Russian FederationФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Министерства здравоохранения Российской ФедерацииРоссияA.I. Yevdokimov Moscow State University of Medicine and DentistryRussian FederationФГБОУ ВО «Санкт-Петербургский государственный педиатрический медицинский университет» Министерства здравоохранения Российской ФедерацииРоссияSaint Petersburg State Pediatric Medical UniversityRussian FederationФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Министерства здравоохранения Российской Федерации; ГБУЗ «Московский клинический научный центр им. А.С. Логинова»РоссияA.I. Yevdokimov Moscow State University of Medicine and Dentistry; A.S. Loginov Moscow Clinical Science CenterRussian FederationФГБУ «Поликлиника № 3» Управления делами Президента Российской ФедерацииРоссияPolyclinic No. 3 of Presidential Administration of Russian FederationRussian FederationМосковский научно-исследовательский онкологический институт им. П.А. Герцена — филиал ФГБУ «Национальный медицинский исследовательский радиологический центр» Министерства здравоохранения Российской ФедерацииРоссияP.A. Hertsen Moscow Oncology Research Center — Branch of “National Medical Research Radiological Center”Russian FederationФГБУ ВО «Ростовский государственный медицинский университет» Министерства здравоохранения Российской ФедерацииРоссияRostov State Medical UniversityRussian FederationФГБУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Министерства здравоохранения Российской ФедерацииРоссияPirogov Russian National Research Medical UniversityRussian Federation202421052024342101131Copyright © Ивашкин В.Т., Маев И.В., Царьков П.В., Королев М.П., Андреев Д.Н., Баранская Е.К., Бордин Д.С., Бурков С.Г., Деринов А.А., Ефетов С.К., Лапина Т.Л., Павлов П.В., Пирогов С.С., Полуэктова Е.А., Ткачев А.В., Трухманов А.С., Ульянин А.И., Федоров Е.Д., Шептулин А.А., 20242024Ивашкин В.Т., Маев И.В., Царьков П.В., Королев М.П., Андреев Д.Н., Баранская Е.К., Бордин Д.С., Бурков С.Г., Деринов А.А., Ефетов С.К., Лапина Т.Л., Павлов П.В., Пирогов С.С., Полуэктова Е.А., Ткачев А.В., Трухманов А.С., Ульянин А.И., Федоров Е.Д., Шептулин А.А.Ivashkin V.Т., Mayev I.V., Tsarkov Р.V., Korolev М.Р., Andreev D.N., Baranskaya Е.К., Bordin D.S., Burkov S.G., Derinov А.А., Efetov S.К., Lapina Т.L., Pavlov Р.V., Pirogov S.S., Poluektova Е.А., Tkachev А.V., Trukhmanov А.S., Uljanin А.I., Fedorov Е.D., Sheptulin А.А.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.gastro-j.ru/jour/article/view/1222Цель

Цель. В клинических рекомендациях, предназначенных для врачей-гастроэнтерологов, врачей общей практики (семейных врачей), врачей-терапевтов, хирургов, эндоскопистов, изложены современные методы диагностики и лечения язвенной болезни.

Основное содержание

Основное содержание. Клинические рекомендации содержат современные представления об этиологии и патогенезе язвенной болезни, ее клинических особенностях, методах лабораторной и инструментальной диагностики, основных подходах к консервативному и хирургическому лечению. В них приводятся критерии оценки качества оказания медицинской помощи, алгоритм действий врача, а также информация для пациента.

Заключение

Заключение. Знание врачами современных методов диагностики и терапии язвенной болезни будет способствовать улучшению результатов ее лечения.

Aim

Aim. The guidelines set out the modern methods of diagnostics and treatment of peptic ulcer and are created for gastroenterologists, primary care physicians, general practitioners, surgeons, endoscopists.

Key points

Key points. The clinical guidelines contain modern views on the etiology and pathogenesis of peptic ulcer, its clinical features, methods of laboratory and instrumental diagnostics, the main approaches to conservative and surgical treatment. They include the criteria for assessment of the quality of medical care, the algorithm of the doctor's actions, as well as information for the patient.

Conclusion

Conclusion. Knowledge of modern methods of diagnostics and therapy of peptic ulcers will contribute to improving the results of its treatment.

язвенная болезньэтиологияпатогенездиагностикалечениеpeptic ulceretiologypathogenesisdiagnosticstreatmentReferencesShay H., Sun D.C.H. Etiology and pathology of gastric and duodenal ulcer. In: Bockus H.L. Gastroenterology. Philadelphia-London: Saunders Elsevier. 1968:420–65.Shay H., Sun D.C.H. Etiology and pathology of gastric and duodenal ulcer. In: Bockus H.L. Gastroenterology. Philadelphia-London: Saunders Elsevier. 1968:420–65.Lanas A., Chan F.K.L. Peptic ulcer disease. Lancet. 2017;390(10094):613–24. DOI: 10.1016/S0140-6736(16)32404-7Lanas A., Chan F.K.L. Peptic ulcer disease. Lancet. 2017;390(10094):613–24. DOI: 10.1016/S0140-6736(16)32404-7Chan F.K.L., Lau J.Y.W. Peptic ulcer disease. In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 10th ed. Philadelphia: Saunders Elsevier, 2015.Chan F.K.L., Lau J.Y.W. Peptic ulcer disease. In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 10th ed. Philadelphia: Saunders Elsevier, 2015.Ramakrishnan K., Salinas R.C. Peptic ulcer disease. Am Fam Physician. 2007;76(7):1005–12.Ramakrishnan K., Salinas R.C. Peptic ulcer disease. Am Fam Physician. 2007;76(7):1005–12.Василенко В.Х., Гребенев А.Л., Шептулин А.А. Язвенная болезнь. М.: Медицина, 1987.Vasilenko VKh., Grebenev A.L., Sheptulin A.A. Peptic ulcer disease. Moscow: Meditsina, 1987. (In Russ.).Lau J.Y., Sung J., Hill C., Henderson C., Howden C.W., Metz D.C. Systematic review of the epidemiology of complicated peptic ulcer disease: Incidence, recurrence, risk factors and mortality. Digestion. 2011;84(2):102–13. DOI: 10.1159/000323958Lau J.Y., Sung J., Hill C., Henderson C., Howden C.W., Metz D.C. Systematic review of the epidemiology of complicated peptic ulcer disease: Incidence, recurrence, risk factors and mortality. Digestion. 2011;84(2):102–13. DOI: 10.1159/000323958Заболеваемость всего населения России в 2006 г. Статистические материалы Минздрава России. М., 2007:98.Morbidity of the entire population of Russia. Statistical materials of the Ministry of Health of Russian Federation. Moscow, 2007:98. (In Russ.).Заболеваемость всего населения России в 2018 г. Статистические материалы Минздрава России. М., 2018:101.Morbidity of the entire population of Russia. Statistical materials of the Ministry of Health of Russian Federation. Moscow, 2018:101. (In Russ.).Hawkey C.J., Wight N.J. Clinician’s manual on NSAIDS and gastrointestinal complications. London: Life Science Communications, 2001.Hawkey C.J., Wight N.J. Clinician’s manual on NSAIDS and gastrointestinal complications. London: Life Science Communications, 2001.Nagashima K., Tominaga K., Fukushi K., Kanamori A., Sasai T., Hiraishi H. Recent trends in the occurrence of bleeding gastric and duodenal ulcers under the Japanese evidence-based clinical practice guideline for peptic ulcer disease. JGH Open. 2018;2(6):255–61. DOI: 10.1002/jgh3.12078Nagashima K., Tominaga K., Fukushi K., Kanamori A., Sasai T., Hiraishi H. Recent trends in the occurrence of bleeding gastric and duodenal ulcers under the Japanese evidence-based clinical practice guideline for peptic ulcer disease. JGH Open. 2018;2(6):255–61. DOI: 10.1002/jgh3.12078Горбашко А.И. Диагностика и лечение кровопотери. Л., Медицина, 1982.Gorbashko A.I. The diagnostics and treatment of the blood loss. Leningrad: Meditsina, 1982. (In Russ.).Heldwein W., Schreiner J., Pedrazzoli J., Lehnert P. Is the Forrest classification a useful tool for planning endoscopic therapy of bleeding peptic ulcers? Endoscopy. 1989;21(6):258–62. DOI: 10.1055/s-2007-1010729Heldwein W., Schreiner J., Pedrazzoli J., Lehnert P. Is the Forrest classification a useful tool for planning endoscopic therapy of bleeding peptic ulcers? Endoscopy. 1989;21(6):258–62. DOI: 10.1055/s-2007-1010729Ивашкин В.Т., Шептулин А.А. Болезни пищевода, желудка и кишечника. М.: МЕДпресс-информ, 2009.Ivashkin V.T., Sheptulin A.A. Diseases of esophagus, stomach and intestines. Moscow: MEDpress-inform, 2009. (In Russ.).Tomizawa M., Shinozaki F., Hasegawa R., Shirai Y., Motoyoshi Y., Sugiyama T., et al. Low hemoglobin levels are associated with upper gastrointestinal bleeding. Biomed Rep. 2016;5(3):349–52. DOI: 10.3892/br.2016.727Tomizawa M., Shinozaki F., Hasegawa R., Shirai Y., Motoyoshi Y., Sugiyama T., et al. Low hemoglobin levels are associated with upper gastrointestinal bleeding. Biomed Rep. 2016;5(3):349–52. DOI: 10.3892/br.2016.727Harewood G.C., McConnel J.P., Harrington J.J., Mahoney D.W., Ahlquist D.A. Detection of occult upper gastrointestinal bleeding: Performance differences in fecal occult blood tests. Mayo Clin Proc. 2002;77(1):23–8. DOI: 10.4065/77.1.23Harewood G.C., McConnel J.P., Harrington J.J., Mahoney D.W., Ahlquist D.A. Detection of occult upper gastrointestinal bleeding: Performance differences in fecal occult blood tests. Mayo Clin Proc. 2002;77(1):23–8. DOI: 10.4065/77.1.23Baghdanian A.H., Baghdanian A.A., Puppala A.A., Tana M., Ohliger M.A. Imaging manifestations of peptic ulcer disease on computed tomography. Semin Ultrasound CT MR. 2018;39(2):183–92. DOI: 10.1053/j.sult.2017.12.002Baghdanian A.H., Baghdanian A.A., Puppala A.A., Tana M., Ohliger M.A. Imaging manifestations of peptic ulcer disease on computed tomography. Semin Ultrasound CT MR. 2018;39(2):183–92. DOI: 10.1053/j.sult.2017.12.002Ecanow J.S., Gore R.M. Evaluating patients with left upper quadrant pain. Radiol Clin North Am. 2015;53(6):1131–57. DOI: 10.1016/j.rcl.2015.06.003Ecanow J.S., Gore R.M. Evaluating patients with left upper quadrant pain. Radiol Clin North Am. 2015;53(6):1131–57. DOI: 10.1016/j.rcl.2015.06.003Thorsen K., Glomsaker T.B., von Meer A., Søreide K., Søreide J.A. Trends in diagnosis and surgical management of patients with perforated peptic ulcer. J Gastrointest Surg. 2011;15(8):1329–35. DOI: 10.1007/s11605-011-1482-1Thorsen K., Glomsaker T.B., von Meer A., Søreide K., Søreide J.A. Trends in diagnosis and surgical management of patients with perforated peptic ulcer. J Gastrointest Surg. 2011;15(8):1329–35. DOI: 10.1007/s11605-011-1482-1Ishiguro T., Kumagai Y., Baba H., Tajima Y., Imaizumi H., Suzuki O., et al. Predicting the amount of intraperitoneal fluid accumulation by computed tomography and its clinical use in patients with perforated peptic ulcer. Int Surg. 2014;99(6):824–9. DOI: 10.9738/INTSURG-D-14-00109.1Ishiguro T., Kumagai Y., Baba H., Tajima Y., Imaizumi H., Suzuki O., et al. Predicting the amount of intraperitoneal fluid accumulation by computed tomography and its clinical use in patients with perforated peptic ulcer. Int Surg. 2014;99(6):824–9. DOI: 10.9738/INTSURG-D-14-00109.1Picone D., Rusignuolo R., Midiri F., Lo Casto A., Vernuccio F., Pinto F., et al. Imaging assessment of gastroduodenal perforations. Semin Ultrasound CT MR. 2016;37(1):16–22. DOI: 10.1053/j.sult.2015.10.006Picone D., Rusignuolo R., Midiri F., Lo Casto A., Vernuccio F., Pinto F., et al. Imaging assessment of gastroduodenal perforations. Semin Ultrasound CT MR. 2016;37(1):16–22. DOI: 10.1053/j.sult.2015.10.006Coppolino F., Gatta G., Di Grezia G., Reginelli A., Iacobellis F., Vallone G., et al. Gastrointestinal perforation: Ultrasonographic diagnosis. Crit Ultrasound J. 2013;5(Suppl 1):S4. DOI: 10.1186/2036-7902-5-S1-S4Coppolino F., Gatta G., Di Grezia G., Reginelli A., Iacobellis F., Vallone G., et al. Gastrointestinal perforation: Ultrasonographic diagnosis. Crit Ultrasound J. 2013;5(Suppl 1):S4. DOI: 10.1186/2036-7902-5-S1-S4Barkun A.N., Bardou M., Kuipers E.J., Sung J., Hunt R.H., Martel M., et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2010;152(2):101–13. DOI: 10.7326/0003-4819-152-2-201001190-00009Barkun A.N., Bardou M., Kuipers E.J., Sung J., Hunt R.H., Martel M., et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2010;152(2):101–13. DOI: 10.7326/0003-4819-152-2-201001190-00009Язвенные гастродуоденальные кровотечения. Клинические рекомендации Российского общества хирургов. Воронеж, 2014:1–9.Gastroduodenal ulcer bleeding. Clinical recommendations of Russian Society of Surgeons. Voronezh, 2014:1–9. (In Russ.).Jiang M., Chen P., Gao Q. Systematic review and network meta-analysis of upper gastrointestinal hemorrhage interventions. Cell Physiol Biochem. 2016;39(6):2477–91. DOI: 10.1159/000452515Jiang M., Chen P., Gao Q. Systematic review and network meta-analysis of upper gastrointestinal hemorrhage interventions. Cell Physiol Biochem. 2016;39(6):2477–91. DOI: 10.1159/000452515Barkun A.N., Martel M., Toubouti Y., Rahme E., Bardou M. Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: A series of meta-analyses. Gastrointest Endosc. 2009;69(4):786–99. DOI: 10.1016/j.gie.2008.05.031Barkun A.N., Martel M., Toubouti Y., Rahme E., Bardou M. Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: A series of meta-analyses. Gastrointest Endosc. 2009;69(4):786–99. DOI: 10.1016/j.gie.2008.05.031Malfertheiner P., Megraud F., Rokkas T., Gisbert J.P., Liou J.-M., Schulz C., et al. Management of Helicobacter pylori infection: The Maastricht VI/Florence consensus report. Gut. 2022;71:1724–62. DOI: 10.1136/gutjnl-2022-327745Malfertheiner P., Megraud F., Rokkas T., Gisbert J.P., Liou J.-M., Schulz C., et al. Management of Helicobacter pylori infection: The Maastricht VI/Florence consensus report. Gut. 2022;71:1724–62. DOI: 10.1136/gutjnl-2022-327745Best L.M., Takwoingi Y., Siddique S., Selladurai A., Gandhi A., Low B., et al. Non-invasive diagnostic tests for Helicobacter pylori infection. Cochrane Database Syst Rev. 2018;3(3):CD012080. DOI: 10.1002/14651858. CD012080.pub2Best L.M., Takwoingi Y., Siddique S., Selladurai A., Gandhi A., Low B., et al. Non-invasive diagnostic tests for Helicobacter pylori infection. Cochrane Database Syst Rev. 2018;3(3):CD012080. DOI: 10.1002/14651858. CD012080.pub2Gisbert J.P., Abraira V. Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: A systematic review and meta-analysis. Am J Gastroenterol. 2006;101(4):848–63. DOI: 10.1111/j.1572-0241.2006.00528.xGisbert J.P., Abraira V. Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: A systematic review and meta-analysis. Am J Gastroenterol. 2006;101(4):848–63. DOI: 10.1111/j.1572-0241.2006.00528.xKim Н. Diagnostic and treatment approaches for refractory ulcers. Clin Endoscop. 2015;48(4):285–90. DOI: 10.5946/ce.2015.48.4.285Kim Н. Diagnostic and treatment approaches for refractory ulcers. Clin Endoscop. 2015;48(4):285–90. DOI: 10.5946/ce.2015.48.4.285Vomero M.D., Colpo E. Nutritional care in peptic ulcer. Arq Bras Cir Dig. 2014;27(4):298–302. DOI: 10.1590/S0102-67202014000400017Vomero M.D., Colpo E. Nutritional care in peptic ulcer. Arq Bras Cir Dig. 2014;27(4):298–302. DOI: 10.1590/S0102-67202014000400017Burget D.W., Chiverton K.D., Hunt R.H. Is there an optimal degree of acid supрression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression. Gastroenterology. 1990;99(2):345– 51. DOI: 10.1016/0016-5085(90)91015-xBurget D.W., Chiverton K.D., Hunt R.H. Is there an optimal degree of acid supрression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression. Gastroenterology. 1990;99(2):345– 51. DOI: 10.1016/0016-5085(90)91015-xScally B., Emberson J.R., Spata E., Reith C., Davies K., Halls H., et al. Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: A meta-analysis of randomized trials. Lancet Gastroenterol Hepatol. 2018;3(4):231–41. DOI: 10.1016/S2468-1253(18)30037-2Scally B., Emberson J.R., Spata E., Reith C., Davies K., Halls H., et al. Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: A meta-analysis of randomized trials. Lancet Gastroenterol Hepatol. 2018;3(4):231–41. DOI: 10.1016/S2468-1253(18)30037-2Poinard T., Lemaire M., Agostini H. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer. Eur J Gastroenterol Hepatol. 1995;7(7):661–5.Poinard T., Lemaire M., Agostini H. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer. Eur J Gastroenterol Hepatol. 1995;7(7):661–5.Hu Z.H., Shi A.M., Hu D.M., Bao J.J. Efficacy of proton pump inhibitors for patients with duodenal ulcers: A pairwise and network meta-analysis of randomized controlled trial. Saudi J Gastroenterol. 2017;23(1):11–9. DOI: 10.4103/1319-3767.199117Hu Z.H., Shi A.M., Hu D.M., Bao J.J. Efficacy of proton pump inhibitors for patients with duodenal ulcers: A pairwise and network meta-analysis of randomized controlled trial. Saudi J Gastroenterol. 2017;23(1):11–9. DOI: 10.4103/1319-3767.199117Terano A., Arakawa Y., Sugiyama H., Suzuki H., Joh T., Yoshikawa T., et al. Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: A randomized, double-blind, placebo-controlled trial. J Gastroenterol. 2007;42(8):690–3. DOI: 10.1007/s00535-007-2076-2Terano A., Arakawa Y., Sugiyama H., Suzuki H., Joh T., Yoshikawa T., et al. Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: A randomized, double-blind, placebo-controlled trial. J Gastroenterol. 2007;42(8):690–3. DOI: 10.1007/s00535-007-2076-2Song K.H., Lee J.C., Fan D.M., Ge Z.Z., Ji F., Chen M.H., et al. Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: A randomized double-blind, multinational comparative study. Digestion. 2011;84(3):221–9. DOI: 10.1159/000329353Song K.H., Lee J.C., Fan D.M., Ge Z.Z., Ji F., Chen M.H., et al. Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: A randomized double-blind, multinational comparative study. Digestion. 2011;84(3):221–9. DOI: 10.1159/000329353Ford A.C., Gurusamy K.S., Delaney B., Forman D., Moayyedi P. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people. Cochrane Database Syst Rev. 2016;4(4):CD003840. DOI: 10.1002/14651858. CD003840.pub5Ford A.C., Gurusamy K.S., Delaney B., Forman D., Moayyedi P. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people. Cochrane Database Syst Rev. 2016;4(4):CD003840. DOI: 10.1002/14651858.CD003840.pub5Wong C.S., Chia C.F., Lee H.C., Wei P.L., Ma H.P., Tsai S.H., et al. Eradication of Helicobacter pylori for prevention of ulcer recurrence after simple closure of perforated peptic ulcer: A meta-analysis of randomized controlled trials. J Surg Res. 2013;182(2):219–26. DOI: 10.1016/j. jss.2012.10.046Wong C.S., Chia C.F., Lee H.C., Wei P.L., Ma H.P., Tsai S.H., et al. Eradication of Helicobacter pylori for prevention of ulcer recurrence after simple closure of perforated peptic ulcer: A meta-analysis of randomized controlled trials. J Surg Res. 2013;182(2):219–26. DOI: 10.1016/j.jss.2012.10.046Ивашкин В.Т., Маев И.В., Лапина Т.Л., Шептулин А.А., Трухманов А.С., Баранская Е.К. и др. Клинические рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению инфекции Helicobacter pylori у взрослых. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2018;28(1):55–70. DOI: 10.22416/1382-4376-2018-28-1-55-70Ivashkin V.T., Mayev I.V., Lapina T.L., Sheptulin A.A., Trukhmanov A.S., Baranskaya Ye.K., et al. Clinical recommendations of the Russian Gastroenterological Association on the diagnosis and treatment of Helicobacter pylori infection in adults. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(1):55–70. (In Russ.). DOI: 10.22416/1382-4376-2018-28-1-55-70Ko S.W., Kim Y.-J., Chung W.C., Lee S.J. Bismuth supplements as the first-line regimen for Helicobacter pylori eradication therapy: Systemic review and meta-analysis. Helicobacter. 2019;24(2):e12565. DOI: 10.1111/ hel.12565Ko S.W., Kim Y.-J., Chung W.C., Lee S.J. Bismuth supplements as the first-line regimen for Helicobacter pylori eradication therapy: Systemic review and meta-analysis. Helicobacter. 2019;24(2):e12565. DOI: 10.1111/hel.12565McNicholl A.G., Bordin D.S., Lucendo A., Fadeenko G., Fernandez M.C., Voynovan I., et al. Combination of bismuth and standard triple therapy eradicates Helicobacter pylori infection in more than 90 % of patients. Clin Gastroenterol Hepatol. 2020;18(1):89–98. DOI: 10.1016/j.cgh.2019.03.048McNicholl A.G., Bordin D.S., Lucendo A., Fadeenko G., Fernandez M.C., Voynovan I., et al. Combination of bismuth and standard triple therapy eradicates Helicobacter pylori infection in more than 90 % of patients. Clin Gastroenterol Hepatol. 2020;18(1):89–98. DOI: 10.1016/j.cgh.2019.03.048Nyssen O.P., Bordin D., Tepes B., Pérez-Aisa Á., Vaira D., Caldas M., et al. European Registry on Helicobacter pylori management (Hp-EuReg): Patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients. Gut. 2021;70(1):40–54. DOI: 10.1136/gutjnl-2020-321372Nyssen O.P., Bordin D., Tepes B., Pérez-Aisa Á., Vaira D., Caldas M., et al. European Registry on Helicobacter pylori management (Hp-EuReg): Patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients. Gut. 2021;70(1):40–54. DOI: 10.1136/gutjnl-2020-321372Yang X., Wang J.X., Han S.X., Gao C.P. High dose dual therapy versus bismuth quadruple therapy for Helicobacter pylori eradication treatment: A systematic review and meta-analysis. Medicine (Baltimore). 2019;98(7):e14396. DOI: 10.1097/MD.0000000000014396Yang X., Wang J.X., Han S.X., Gao C.P. High dose dual therapy versus bismuth quadruple therapy for Helicobacter pylori eradication treatment: A systematic review and meta-analysis. Medicine (Baltimore). 2019;98(7):e14396. DOI: 10.1097/MD.0000000000014396Guo B., Cao N.W., Zhou H.Y., Chu X.J., Li B.Z. Efficacy and safety of bismuth-containing quadruple treatment and concomitant treatment for first-line Helicobacter pylori eradication: A systematic review and meta-analysis. Microb Pathog. 2021;152:104661. DOI: 10.1016/j.micpath.2020.104661Guo B., Cao N.W., Zhou H.Y., Chu X.J., Li B.Z. Efficacy and safety of bismuth-containing quadruple treatment and concomitant treatment for first-line Helicobacter pylori eradication: A systematic review and meta-analysis. Microb Pathog. 2021;152:104661. DOI: 10.1016/j.micpath.2020.104661Yuan Y., Ford A.C., Khan K.J., Gisbert J.P., Forman D., Leontiadis G.I., et al. Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev. 2013;12:CD008337. DOI: 10.1002/14651858. CD008337.pub2Yuan Y., Ford A.C., Khan K.J., Gisbert J.P., Forman D., Leontiadis G.I., et al. Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev. 2013;12:CD008337. DOI: 10.1002/14651858. CD008337.pub2Villoria A., Garcia P., Calvet X., Gisbert J.P., Vergara M. Meta-analysis: High-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2008;28(7):868–77. DOI: 10.1111/j.1365-2036.2008.03807.xVilloria A., Garcia P., Calvet X., Gisbert J.P., Vergara M. Meta-analysis: High-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2008;28(7):868–77. DOI: 10.1111/j.1365-2036.2008.03807.xGao W., Zhang X., Yin Y., Yu S., Wang L. Different dose of new generation proton pump inhibitors for the treatment of Helicobacter pylori infection: A meta-analysis. Int J Immunopathol Pharmacol. 2021;35:20587384211030397. DOI: 10.1177/20587384211030397Gao W., Zhang X., Yin Y., Yu S., Wang L. Different dose of new generation proton pump inhibitors for the treatment of Helicobacter pylori infection: A meta-analysis. Int J Immunopathol Pharmacol. 2021;35:20587384211030397. DOI: 10.1177/20587384211030397Tang H.L., Li Y., Hu Y.F., Xie H.G., Zhai S.D. Effects of CYP2C19 loss-of-function variants on the eradication of H. pylori infection in patients treated with proton pump inhibitor-based triple therapy regimens: A meta-analysis of randomized clinical trials. PLoS One. 2013;8(4):e62162. DOI: 10.1371/journal.pone.0062162Tang H.L., Li Y., Hu Y.F., Xie H.G., Zhai S.D. Effects of CYP2C19 loss-of-function variants on the eradication of H. pylori infection in patients treated with proton pump inhibitor-based triple therapy regimens: A meta-analysis of randomized clinical trials. PLoS One. 2013;8(4):e62162. DOI: 10.1371/journal.pone.0062162Jung Y.S., Kim E.H., Park C.H. Systematic review with meta-analysis: The efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication. Aliment Pharmacol Ther. 2017;46(2):106–14. DOI: 10.1111/apt.14130Jung Y.S., Kim E.H., Park C.H. Systematic review with meta-analysis: The efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication. Aliment Pharmacol Ther. 2017;46(2):106–14. DOI: 10.1111/apt.14130Shinozaki S., Kobayashi Y., Osawa H., Sakamoto H., Hayashi Y., Lefor A.K., et al. Effectiveness and safety of vonoprazan versus proton pump inhibitors for second-line Helicobacter pylori eradication therapy: Systematic review and meta-analysis. Digestion. 2021;102(3):319–25. DOI: 10.1159/000504939Shinozaki S., Kobayashi Y., Osawa H., Sakamoto H., Hayashi Y., Lefor A.K., et al. Effectiveness and safety of vonoprazan versus proton pump inhibitors for second-line Helicobacter pylori eradication therapy: Systematic review and meta-analysis. Digestion. 2021;102(3):319–25. DOI: 10.1159/000504939Chang Y.L., Tung Y.C., Tu Y.K., Yeh H.Z., Yang J.C., Hsu P.I., et al. Efficacy of second-line regimens for Helicobacter pylori eradication treatment: A systemic review and network meta-analysis. BMJ Open Gastroenterol. 2020;7(1):e000472. DOI: 10.1136/bmjgast-2020-000472Chang Y.L., Tung Y.C., Tu Y.K., Yeh H.Z., Yang J.C., Hsu P.I., et al. Efficacy of second-line regimens for Helicobacter pylori eradication treatment: A systemic review and network meta-analysis. BMJ Open Gastroenterol. 2020;7(1):e000472. DOI: 10.1136/bmjgast-2020-000472Han Z., Li Y., Kong Q., Liu J., Wang J., Wan M., et al. Efficacy of bismuth for antibiotic-resistant Helicobacter pylori strains eradication: A systematic review and meta-analysis. Helicobacter. 2022;27(6):e12930. DOI: 10.1111/hel.12930Han Z., Li Y., Kong Q., Liu J., Wang J., Wan M., et al. Efficacy of bismuth for antibiotic-resistant Helicobacter pylori strains eradication: A systematic review and meta-analysis. Helicobacter. 2022;27(6):e12930. DOI: 10.1111/hel.12930Yeo Y.H., Hsu C.C., Lee C.C., Ho H.J., Lin J.T., Wu M.S., et al. Systematic review and network meta-analysis: Comparative effectiveness of therapies for second-line Helicobacter pylori eradication. J Gastroenterol Hepatol. 2019;34(1):59–67. DOI: 10.1111/jgh.14462Yeo Y.H., Hsu C.C., Lee C.C., Ho H.J., Lin J.T., Wu M.S., et al. Systematic review and network meta-analysis: Comparative effectiveness of therapies for second-line Helicobacter pylori eradication. J Gastroenterol Hepatol. 2019;34(1):59–67. DOI: 10.1111/jgh.14462Mori H., Suzuki H. Update on quinolone-containing rescue therapies for Helicobacter pylori infection. World J Gastroenterol. 2020;26(15):1733–44. DOI: 10.3748/wjg.v26.i15.1733Mori H., Suzuki H. Update on quinolone-containing rescue therapies for Helicobacter pylori infection. World J Gastroenterol. 2020;26(15):1733–44. DOI: 10.3748/wjg.v26.i15.1733Nishizawa T., Nishizawa Y., Yahagi N., Kanai T., Takahashi M., Suzuki H. Effect of supplementation with rebamipide for Helicobacter pylori eradication therapy: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2014;29(Suppl. 4):20–4. DOI: 10.1111/jgh.12769Nishizawa T., Nishizawa Y., Yahagi N., Kanai T., Takahashi M., Suzuki H. Effect of supplementation with rebamipide for Helicobacter pylori eradication therapy: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2014;29(Suppl. 4):20–4. DOI: 10.1111/jgh.12769Andreev D.N., Maev I.V., Dicheva D.T. Efficiency of the inclusion of rebamipide in the eradication therapy for Helicobacter pylori infection: Meta-analysis of randomized controlled studies. J Clin Med. 2019;8(9):1498. DOI: 10.3390/jcm8091498Andreev D.N., Maev I.V., Dicheva D.T. Efficiency of the inclusion of rebamipide in the eradication therapy for Helicobacter pylori infection: Meta-analysis of randomized controlled studies. J Clin Med. 2019;8(9):1498. DOI: 10.3390/jcm8091498Graham D.Y., Lew G.M., Malaty H.M., Evans D.G., Evans D.J.Jr., Klein P.D., et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology. 1992;102(2):493–6. DOI: 10.1016/0016-5085(92)90095-gGraham D.Y., Lew G.M., Malaty H.M., Evans D.G., Evans D.J.Jr., Klein P.D., et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology. 1992;102(2):493–6. DOI: 10.1016/0016085(92)90095-gKim B.J., Lee H., Lee Y.C., Jeon S.W., Kim G.H., Kim H.S., et al. Ten-day concomitant, 10-day sequential, and 7-day triple therapy as first-line treatment for Helicobacter pylori infection: A nationwide randomized trial in Korea. Gut Liver. 2019;13(5):531–40. DOI: 10.5009/gnl19136Kim B.J., Lee H., Lee Y.C., Jeon S.W., Kim G.H., Kim H.S., et al. Ten-day concomitant, 10-day sequential, and 7-day triple therapy as first-line treatment for Helicobacter pylori infection: A nationwide randomized trial in Korea. Gut Liver. 2019;13(5):531–40. DOI: 10.5009/gnl19136Минушкин О.Н., Зверков И.В., Володин Д.В., Иванова Е.И., Шулешова А.Г. Эффективность препарата «Пилобакт AM» в эрадикационной терапии язвенной болезни двенадцатиперстной кишки. Врач. 2008;5:67–9.Minushkin O.N., Zverkov I.V., Volodin D.V., Ivanova E.I., Shuleshova A.G. The efficacy of the preparation “Pylobact AM” in the eradication therapy of duodenal ulcer. Vrach. 2008;5:67–9. (In Russ.).McFarland L.V., Malfertheiner P., Huang Y., Wang L. Meta-analysis of single strain probiotics for the eradication of Helicobacter pylori and prevention of adverse events. World Journal of Meta-Analysis. 2015;3(2):97–117. DOI: 10.13105/wjma.v3.i2.97McFarland L.V., Malfertheiner P., Huang Y., Wang L. Meta-analysis of single strain probiotics for the eradication of Helicobacter pylori and prevention of adverse events. World Journal of Meta-Analysis. 2015;3(2):97–117. DOI: 10.13105/wjma.v3.i2.97Zhou B.G., Chen L.X., Li B., Wan L.Y., Ai Y.W. Saccharomyces boulardii as an adjuvant therapy for Helicobacter pylori eradication: A systematic review and meta-analysis with trial sequential analysis. Helicobacter. 2019;24(5):e12651. DOI: 10.1111/hel.12651Zhou B.G., Chen L.X., Li B., Wan L.Y., Ai Y.W. Saccharomyces boulardii as an adjuvant therapy for Helicobacter pylori eradication: A systematic review and meta-analysis with trial sequential analysis. Helicobacter. 2019;24(5):e12651. DOI: 10.1111/hel.12651McFarland L.V., Huang Y., Wang L., Malfertheiner P. Systematic review and meta-analysis: Multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events. United European Gastroenterol J. 2016;4(4):546–61. DOI: 10.1177/2050640615617358McFarland L.V., Huang Y., Wang L., Malfertheiner P. Systematic review and meta-analysis: Multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events. United European Gastroenterol J. 2016;4(4):546–61. DOI: 10.1177/2050640615617358Szajewska H., Horvath A., Piwowarczyk A. Meta-analysis: The effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment. Aliment Pharmacol Ther. 2010;32(9):1069–79. DOI: 10.1111/j.1365-2036.2010.04457.xSzajewska H., Horvath A., Piwowarczyk A. Meta-analysis: The effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment. Aliment Pharmacol Ther. 2010;32(9):1069–79. DOI: 10.1111/j.1365-2036.2010.04457.xSzajewska H., Horvath A., Kołodziej M. Systematic review with meta-analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection. Aliment Pharmacol Ther. 2015;41(12):1237–45. DOI: 10.1111/apt.13214Szajewska H., Horvath A., Kołodziej M. Systematic review with meta-analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection. Aliment Pharmacol Ther. 2015;41(12):1237–45. DOI: 10.1111/apt.13214Dang Y., Reinhardt J.D., Zhou X., Zhang G. The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: A meta-analysis. PLoS One. 2014;9(11):e111030. DOI: 10.1371/journal.pone.0111030Dang Y., Reinhardt J.D., Zhou X., Zhang G. The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: A meta-analysis. PLoS One. 2014;9(11):e111030. DOI: 10.1371/journal.pone.0111030Lv Z., Wang B., Zhou X., Wang F., Xie Y., Zheng H., et al. Efficacy and safety of probiotics as adjuvant agents for Helicobacter pylori infection: A meta-analysis. Exp Ther Med. 2015;9(3):707–16. DOI: 10.3892/etm.2015.2174Lv Z., Wang B., Zhou X., Wang F., Xie Y., Zheng H., et al. Efficacy and safety of probiotics as adjuvant agents for Helicobacter pylori infection: A meta-analysis. Exp Ther Med. 2015;9(3):707–16. DOI: 10.3892/etm.2015.2174Zheng X., Lyu L., Mei Z. Lactobacillus-containing probiotic supplementation increases Helicobacter pylori eradication rate: Evidence from a meta-analysis. Rev Esp Enferm Dig. 2013;105(8):445–53. DOI: 10.4321/s1130-01082013000800002Zheng X., Lyu L., Mei Z. Lactobacillus-containing probiotic supplementation increases Helicobacter pylori eradication rate: Evidence from a meta-analysis. Rev Esp Enferm Dig. 2013;105(8):445–53. DOI: 10.4321/s1130-01082013000800002Goodman C., Keating G., Georgousopoulou E., Hespe C., Levett K. Probiotics for the prevention of antibiotic-associated diarrhoea: A systematic review and meta-analysis. BMJ Open. 2021;11(8):e043054. DOI: 10.1136/bmjopen-2020-043054Goodman C., Keating G., Georgousopoulou E., Hespe C., Levett K. Probiotics for the prevention of antibiotic-associated diarrhoea: A systematic review and meta-analysis. BMJ Open. 2021;11(8):e043054. DOI: 10.1136/bmjopen-2020-043054Goldenberg J.Z., Yap C., Lytvyn L., Lo C.K., Beardsley J., Mertz D., et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2017;12(12):CD006095. DOI: 10.1002/14651858.CD006095.pub4Goldenberg J.Z., Yap C., Lytvyn L., Lo C.K., Beardsley J., Mertz D., et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2017;12(12):CD006095. DOI: 10.1002/14651858.CD006095.pub4Cárdenas P.A., Garcés D., Prado-Vivar B., Flores N., Fornasini M., Cohen H., et al. Effect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome. Eur J Clin Microbiol Infect Dis. 2020;39(7):1365–72. DOI: 10.1007/s10096-020-03854-3Cárdenas P.A., Garcés D., Prado-Vivar B., Flores N., Fornasini M., Cohen H., et al. Effect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome. Eur J Clin Microbiol Infect Dis. 2020;39(7):1365–72. DOI: 10.1007/s10096-020-03854-3Seddik H., Boutallaka H., Elkoti I., Nejjari F., Berraida R., Berrag S., et al. Saccharomyces boulardii CNCM I-745 plus sequential therapy for Helicobacter pylori infections: A randomized, open-label trial. Eur J Clin Pharmacol. 2019;75(5):639–45. DOI: 10.1007/s00228-019-02625-0Seddik H., Boutallaka H., Elkoti I., Nejjari F., Berraida R., Berrag S., et al. Saccharomyces boulardii CNCM I-745 plus sequential therapy for Helicobacter pylori infections: A randomized, open-label trial. Eur J Clin Pharmacol. 2019;75(5):639–45. DOI: 10.1007/s00228-019-02625-0Martín R., Langella P. Emerging health concepts in the probiotics field: Streamlining the definitions. Front Microbiol. 2019;10:1047. DOI: 10.3389/fmicb.2019.01047Martín R., Langella P. Emerging health concepts in the probiotics field: Streamlining the definitions. Front Microbiol. 2019;10:1047. DOI: 10.3389/fmicb.2019.01047Shenderov B.A. Metabiotics: Novel idea or natural development of probiotic conception. Microb Ecol Health Dis. 2013:24. DOI: 10.3402/mehd.v24i0.20399Shenderov B.A. Metabiotics: Novel idea or natural development of probiotic conception. Microb Ecol Health Dis. 2013:24. DOI: 10.3402/mehd.v24i0.20399Parth K., Prudhivi R., Palatheeya S., Abbas S.K., Varsha K., Niharika B.V., et al. Efficacy of Lactobacillus reuteri supplementation in eradication of H. pylori: A comparison study with triple drug therapy. J Pharm Res Inter. 2021;33(52B):151–9.Parth K., Prudhivi R., Palatheeya S., Abbas S.K., Varsha K., Niharika B.V., et al. Efficacy of Lactobacillus reuteri supplementation in eradication of H. pylori: A comparison study with triple drug therapy. J Pharm Res Inter. 2021;33(52B):151–9.Toewas I., George A.T., Peter J.V., Kirubakaran R., Fontes L.E.S., Ezekiel J.P.B., et al. Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units. Cochrane Datadase Syst Rev. 2018;6(6):CD008687. DOI: 10.1002/14651858. CD008687.pub2Toewas I., George A.T., Peter J.V., Kirubakaran R., Fontes L.E.S., Ezekiel J.P.B., et al. Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units. Cochrane Datadase Syst Rev. 2018;6(6):CD008687. DOI: 10.1002/14651858. CD008687.pub2Евсеев М.А., Клишин И.М. Эффективность антисекреторной терапии ингибиторами протонной помпы при гастродуоденальных язвенных кровотечениях. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2010;20(3):55–62.Evseev M.A., Klishin I.M. The effectiveness of the antisecretory therapy with proton pump inhibitors in gastroduodenal ulcer bleeding. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2010;20(3):55–62. (In Russ.).Syam A.F., Setiawati A. Safety and efficacy of lansoprazole injection in upper gastrointestinal bleeding: A postmarketing surveillance conducted in Indonesia. Acta Med Indones. 2013;45(2):123–9.Syam A.F., Setiawati A. Safety and efficacy of lansoprazole injection in upper gastrointestinal bleeding: A postmarketing surveillance conducted in Indonesia. Acta Med Indones. 2013;45(2):123–9.Barkun A., Almadi M., Kuipers E.J., Laine L., Sung J., Tse F., et al. Management of nonvariceal upper gastrointestinal bleeding: Guideline recommendations from the international consensus group. Ann Inter Med. 2019:171(11):805–22. DOI: 10.7326/M19-1795Barkun A., Almadi M., Kuipers E.J., Laine L., Sung J., Tse F., et al. Management of nonvariceal upper gastrointestinal bleeding: Guideline recommendations from the international consensus group. Ann Inter Med. 2019:171(11):805–22. DOI: 10.7326/M19-1795Tarasconii A., Coccolini F., Biffl W.L., Tomasoni M., Ansaloni L., Picetti E., et al. Perforated and bleeding peptic ulcer: WSES guidelines. World J Emerg Surg. 2020;15:3. DOI: 10.1186/s13017-019-0283-9Tarasconii A., Coccolini F., Biffl W.L., Tomasoni M., Ansaloni L., Picetti E., et al. Perforated and bleeding peptic ulcer: WSES guidelines. World J Emerg Surg. 2020;15:3. DOI: 10.1186/s13017-019-0283-9Sung J.J.Y, Chiu P.W.Y., Chan F.K.L., Lau J.Y., Goh K.L., Ho L.H., et al. Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding. Gut. 2018;67(10):1757–68. DOI: 10.1136/gutjnl-2018-316276Sung J.J.Y, Chiu P.W.Y., Chan F.K.L., Lau J.Y., Goh K.L., Ho L.H., et al. Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding. Gut. 2018;67(10):1757–68. DOI: 10.1136/gutjnl-2018-316276Elmunzer B.J., Young S.D., Inadoni J.M., Schoenfeld P., Laine L. Systematic review of the predictors of recurrent hemorrhage after endoscopic hemostatic therapy for bleeding peptic ulcers. Am J Gastroenterol. 2008;103(10):2625– 32. DOI: 10.1111/j.1572-0241.2008.02070.xElmunzer B.J., Young S.D., Inadoni J.M., Schoenfeld P., Laine L. Systematic review of the predictors of recurrent hemorrhage after endoscopic hemostatic therapy for bleeding peptic ulcers. Am J Gastroenterol. 2008;103(10):2625– 32. DOI: 10.1111/j.1572-0241.2008.02070.xSatoh K., Yoshino J., Akamatsu T., Itoh T., Kato M., Kamada T., et al. Evidence-based clinical practice guidelines for peptic ulcer disease 2015. J Gastroenterol. 2016;51(3):177–94. DOI: 10.1007/s00535-016-1166-4Satoh K., Yoshino J., Akamatsu T., Itoh T., Kato M., Kamada T., et al. Evidence-based clinical practice guidelines for peptic ulcer disease 2015. J Gastroenterol. 2016;51(3):177–94. DOI: 10.1007/s00535-016-1166-4Gurusamy K.S., Pallari E. Medical versus surgical treatment for refractory or recurrent peptic ulcer. Cochrane Database Syst Rev. 2016;3(3):CD011523. DOI: 10.1002/14651858.CD011523.pub2Gurusamy K.S., Pallari E. Medical versus surgical treatment for refractory or recurrent peptic ulcer. Cochrane Database Syst Rev. 2016;3(3):CD011523. DOI: 10.1002/14651858.CD011523.pub2Прободная язва у взрослых. Клинические рекомендации Российского общества хирургов. M.: МЗ РФ, 2016.The perforated ulcer in adults. Clinical recommendations of Russian Society of Surgeons. Moscow: The Ministry of Health of Russian Federation, 2016. (In Russ.).Тарасенко С.В., Зайцев О.В., Кочуков В.П., Копейкин А.А., Натальский А.А., Богомолов А.Ю. Хирургия осложненной язвенной болезни. Воронеж: Проспект, 2015.Tarasenko S.V., Zaitsev O.V., Kochukov V.P., Kopeykin A.A., Natalskiy A.A., Bogomolov A.Yu. The surgery of complicated peptic ulcer disease. Voronezh: Prospekt Publ., 2016. (In Russ.).Chatten K., Pursell H., Banerjee A.K., Soteriadou S., Ang Y. Glasgow Blatchford Score and risk stratifications in acute upper gastrointestinal bleed: Can we extend this to 2 for urgent outpatient management? Clin Med (London). 2018;18(2):118–22. DOI: 10.7861/clinmedicine.18-2-118Chatten K., Pursell H., Banerjee A.K., Soteriadou S., Ang Y. Glasgow Blatchford Score and risk stratifications in acute upper gastrointestinal bleed: Can we extend this to 2 for urgent outpatient management? Clin Med (London). 2018;18(2):118–22. DOI: 10.7861/clinmedicine.18-2-118Farrar F.C. Management of acute gastrointestinal bleeding. Crit Care Nurs Clin North Am. 2018;30(1):55–66. DOI: 10.1016/j.cnc.2017.10.005Farrar F.C. Management of acute gastrointestinal bleeding. Crit Care Nurs Clin North Am. 2018;30(1):55–66. DOI: 10.1016/j.cnc.2017.10.005Leontiadis G.I., Molloy-Bland M., Moayyedi P., Howden C.W. Effect of comorbidity on mortality in patients with peptic ulcer bleeding: Systematic review and meta-analysis. Am J Gastroenterol. 2013;108(3):331–45. DOI: 10.1038/ajg.2012.451Leontiadis G.I., Molloy-Bland M., Moayyedi P., Howden C.W. Effect of comorbidity on mortality in patients with peptic ulcer bleeding: Systematic review and meta-analysis. Am J Gastroenterol. 2013;108(3):331–45. DOI: 10.1038/ajg.2012.451Møller M.H., Adamsen S., Thomsen R.W., Møller A.M. Preoperative prognostic factors for mortality in peptic ulcer perforation: A systematic review. Scand J Gastroenterol. 2010;45(7–8):785–805. DOI: 10.3109/00365521003783320Møller M.H., Adamsen S., Thomsen R.W., Møller A.M. Preoperative prognostic factors for mortality in peptic ulcer perforation: A systematic review. Scand J Gastroenterol. 2010;45(7–8):785–805. DOI: 10.3109/00365521003783320Morris D.L., Hawker P.C., Brearley S., Simms M., Dykes P.W., Keighley M.R. Optimal timing of operation for bleeding peptic ulcer: Prospective randomized trial. Br Med J (Clin Res Ed). 1984;288(6426):1277–80. DOI: 10.1136/bmj.288.6426.1277Morris D.L., Hawker P.C., Brearley S., Simms M., Dykes P.W., Keighley M.R. Optimal timing of operation for bleeding peptic ulcer: Prospective randomized trial. Br Med J (Clin Res Ed). 1984;288(6426):1277–80. DOI: 10.1136/bmj.288.6426.1277Lagoo J., Pappas T.N., Perez A. A relic or still relevant: The narrowing role for vagotomy in the treatment of peptic ulcer disease. Am J Surg. 2014;207(1):120–6. DOI: 10.1016/j.amjsurg.2013.02.012Lagoo J., Pappas T.N., Perez A. A relic or still relevant: The narrowing role for vagotomy in the treatment of peptic ulcer disease. Am J Surg. 2014;207(1):120–6. DOI: 10.1016/j.amjsurg.2013.02.012Søreide K., Thorsen K., Harrison E.M., Bingener J., Møller M.H., Ohene-Yeboah M., et al. Perforated peptic ulcer. Lancet. 2015;386(10000):1288–98. DOI: 10.1016/S0140-6736(15)00276-7Søreide K., Thorsen K., Harrison E.M., Bingener J., Møller M.H., Ohene-Yeboah M., et al. Perforated peptic ulcer. Lancet. 2015;386(10000):1288–98. DOI: 10.1016/S0140-6736(15)00276-7Tomtitchong P., Siribumrungwomg B., Vilaichone R.K., Kasetsuwan P., Matsukura N., Chaiyakunapruk N. Systematic review and meta-analysis: Helicobacter pylori eradication therapy after simple closure of perforated duodenal ulcer. Helicobacter. 2012;17(2):148–52. DOI: 10.1111.j.1523-5378.2011.00928.xTomtitchong P., Siribumrungwomg B., Vilaichone R.K., Kasetsuwan P., Matsukura N., Chaiyakunapruk N. Systematic review and meta-analysis: Helicobacter pylori eradication therapy after simple closure of perforated duodenal ulcer. Helicobacter. 2012;17(2):148–52. DOI: 10.1111.j.1523-5378.2011.00928.xSharma V.K., Sahai A.V., Corder F.A., Howden C.W. Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage. Aliment Pharmacol Ther. 2001;15(12):1939– 47. DOI: 10.1046/j.1365-2036.2001.01134.xSharma V.K., Sahai A.V., Corder F.A., Howden C.W. Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage. Aliment Pharmacol Ther. 2001;15(12):1939– 47. DOI: 10.1046/j.1365-2036.2001.01134.xМаев И.В., Самсонов А.А. Язвенная болезнь двенадцатиперстной кишки: различные подходы к современной консервативной терапии. Consilium medicum. 2004;(1):6–11.Mayev I.V., Samsonov A.A. Duodenal peptic ulcer: Various approaches to modern conservative therapy. Consilium medicum. 2004;(1):6–11. (In Russ.).Бурков С.Г. Заболевания органов пищеварения у беременных. М.: КРОН-ПРЕСС, 1996. ORCID: http//orcid.org/0000-0001-7404-5859Burkov S.G. Diseases of the digestive system in pregnant women. Moscow: KRON-PRESS Publ., 1996. (In Russ.). ORCID: http//orcid.org/0000-0001-7404-5859Cappell M.S. The fetal safety and clinical efficacy of gastrointestinal endoscopy during pregnancy. Gastroenterol Clin North Am. 2003;32(1):123–79. DOI: 10.1016/s0889-8553(02)00137-1Cappell M.S. The fetal safety and clinical efficacy of gastrointestinal endoscopy during pregnancy. Gastroenterol Clin North Am. 2003;32(1):123–79. DOI: 10.1016/s0889-8553(02)00137-1

The authors declare that there are no conflicts of interest present.